Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
| Period | Value | YoY Change |
|---|---|---|
| TTM | $63.70M | -66.7% |
| 2024 | $191.37M | -30.6% |
| 2023 | $275.69M | -19.9% |
| 2022 | $344.09M | +336.7% |
| 2021 | $78.80M | +22.4% |
| 2020 | $64.40M | -78.2% |
| 2019 | $295.68M | +24.7% |
| 2018 | $237.11M | +95.1% |
| 2017 | $121.53M | +49.6% |
| 2016 | $81.24M | - |